1076.5500 10.80 (1.01%)
NSE Mar 19, 2025 09:28 AM
Volume: 9,688
 

1076.55
1.01%
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
Alivus Life Sciences Ltd. has gained 41.71% in the last 1 Year
More from Alivus Life Sciences Ltd.
Recommended